ATCC (American Type Culture Collection)
ATCC (American Type Culture Collection) is a nonprofit, global, biological resource center and standards organization. It is the leading developer and supplier of authenticated cell lines and microorganisms, leveraging its rich history and knowledge to provide essential products, services, and resources for critical life science research. ATCC is also recognized as a Great Place To Work Certified™ company, emphasizing a collaborative, diverse, and innovative culture that supports scientific advancement and global health protection.
ATCC (American Type Culture Collection)
10801 University Blvd, Manassas, VA 20110, USA
What We Do
ATCC offers a wide range of cell products including primary cells, cell models, and assay-ready cells for various research applications.
ATCC provides a comprehensive collection of microbial strains for research and quality control purposes.
ATCC offers various services including cell authentication, microbial identification, and custom solutions to support scientific research.
ATCC provides solutions tailored for federal agencies, supporting their research and development needs.
ATCC supports each stage of the diagnostic development process by providing authenticated live strains, quantitative molecular standards, and next-generation sequencing standards.
ATCC supports bioproduction research and development projects by providing resources for industrial bioprocessing and cell-based applications, including cell lines for enhanced virus production and microbial bioproduction.
Services
Show More (2)Key People
Senior Vice President, ATCC Federal Solutions
Senior Director of Business Development, ATCC Federal Solutions (AFS)
Director, Government Programs, ATCC Federal Solutions (AFS)
Director, Contracts, ATCC Federal Solutions (AFS)
News & Updates
Ruth Cheng, appointed new president and CEO of ATCC, succeeds Raymond Cypess, who will remain on the Board of Directors as chairman.
NCI awarded ATCC a 5-year contract with a ceiling value of $4.06 million to provide lab services that support HIV and HTLV-1 research and vaccine development.
ATCC awarded a one-year, subaward in the amount of $165,962 from NIAID to collaborate on babesiosis and tickborne disease research.
ATCC received a C06 Research Facilities Construction Grant from ORIP, part of the NIH, to support the building of ATCC’s new biomanufacturing suite at its headquarters in Manassas, VA.
ATCC was awarded a contract to develop well-characterized challenge materials, enhancing their capabilities in infectious disease research.
A discussion on the importance of a unified approach to infectious disease management.